Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23348 | 294 | 18.1 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2212 | 4375 | RHENIUMV//TECHNETIUM COMPLEXES//OXORHENIUMV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TC 99M V DMSA | Author keyword | 15 | 71% | 4% | 12 |
2 | BIOPHYS RADIOPHARMACEUT | Address | 15 | 88% | 2% | 7 |
3 | TC 99M VDMSA | Author keyword | 8 | 75% | 2% | 6 |
4 | PENTAVALENT TECHNETIUM 99M DIMERCAPTOSUCCINIC ACID | Author keyword | 8 | 100% | 2% | 5 |
5 | TCV DMS | Author keyword | 6 | 100% | 1% | 4 |
6 | PENTAVALENT TC 99M DMSA | Author keyword | 4 | 67% | 1% | 4 |
7 | PENTAVALENT TECHNETIUM 99M DMSA | Author keyword | 3 | 100% | 1% | 3 |
8 | PH SENSITIVE AGENT | Author keyword | 3 | 100% | 1% | 3 |
9 | RE 188V DMSA | Author keyword | 3 | 100% | 1% | 3 |
10 | TC 99M GLUTATHIONE | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TC 99M V DMSA | 15 | 71% | 4% | 12 | Search TC+99M+V+DMSA | Search TC+99M+V+DMSA |
2 | TC 99M VDMSA | 8 | 75% | 2% | 6 | Search TC+99M+VDMSA | Search TC+99M+VDMSA |
3 | PENTAVALENT TECHNETIUM 99M DIMERCAPTOSUCCINIC ACID | 8 | 100% | 2% | 5 | Search PENTAVALENT+TECHNETIUM+99M+DIMERCAPTOSUCCINIC+ACID | Search PENTAVALENT+TECHNETIUM+99M+DIMERCAPTOSUCCINIC+ACID |
4 | TCV DMS | 6 | 100% | 1% | 4 | Search TCV+DMS | Search TCV+DMS |
5 | PENTAVALENT TC 99M DMSA | 4 | 67% | 1% | 4 | Search PENTAVALENT+TC+99M+DMSA | Search PENTAVALENT+TC+99M+DMSA |
6 | PENTAVALENT TECHNETIUM 99M DMSA | 3 | 100% | 1% | 3 | Search PENTAVALENT+TECHNETIUM+99M+DMSA | Search PENTAVALENT+TECHNETIUM+99M+DMSA |
7 | PH SENSITIVE AGENT | 3 | 100% | 1% | 3 | Search PH+SENSITIVE+AGENT | Search PH+SENSITIVE+AGENT |
8 | RE 188V DMSA | 3 | 100% | 1% | 3 | Search RE+188V+DMSA | Search RE+188V+DMSA |
9 | TC 99M GLUTATHIONE | 3 | 100% | 1% | 3 | Search TC+99M+GLUTATHIONE | Search TC+99M+GLUTATHIONE |
10 | TC 99MV DMSA | 2 | 40% | 1% | 4 | Search TC+99MV+DMSA | Search TC+99MV+DMSA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TUMOR SEEKING AGENT | 32 | 88% | 5% | 15 |
2 | PENTAVALENT TECHNETIUM 99M DMSA | 12 | 86% | 2% | 6 |
3 | TCV DMS | 11 | 100% | 2% | 6 |
4 | DIMERCAPTOSUCCINIC ACID | 8 | 17% | 14% | 41 |
5 | TC 99M V DMSA UPTAKE | 6 | 71% | 2% | 5 |
6 | SEEKING AGENT | 6 | 58% | 2% | 7 |
7 | TC 99MV DMSA | 6 | 100% | 1% | 4 |
8 | V DIMERCAPTOSUCCINIC ACID | 3 | 50% | 2% | 5 |
9 | DMSA | 3 | 12% | 8% | 23 |
10 | TC 99M DIMERCAPTOSUCCINIC ACID | 1 | 18% | 2% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Relationship of cell proliferation (Ki-67) to Tc-99m-(V) DMSA uptake in breast cancer | 2004 | 19 | 21 | 48% |
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography | 2005 | 16 | 32 | 22% |
Radiolabeling in Biology | 2015 | 0 | 5 | 40% |
NUCLEAR-MEDICINE IN OTOLARYNGOLOGY | 1990 | 9 | 26 | 27% |
Review of the contribution of radiolabelled tracers for tumour cell status imaging | 2006 | 3 | 105 | 12% |
IMAGING HEAD AND NECK-CANCER USING RADIOISOTOPES - A REVIEW | 1988 | 1 | 26 | 31% |
Interstitial lymphoscintigraphy for lymphatic mapping in surgical practice and research | 1997 | 15 | 51 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOPHYS RADIOPHARMACEUT | 15 | 88% | 2.4% | 7 |
2 | CELL DEATH NEOPLASIA GRP | 1 | 50% | 0.7% | 2 |
3 | CELL SURVIVAL ADHES GRP | 1 | 100% | 0.7% | 2 |
4 | PATHOFUNCT BIOANALSAKYO KU | 1 | 100% | 0.7% | 2 |
5 | JACQUES LISFRANC MED | 1 | 25% | 1.0% | 3 |
6 | GRP CELL DEATH NEOPLASIA | 1 | 50% | 0.3% | 1 |
7 | INMOL | 0 | 33% | 0.3% | 1 |
8 | CLIN NUCLEAR MED | 0 | 25% | 0.3% | 1 |
9 | RUMIA | 0 | 25% | 0.3% | 1 |
10 | TRIGA REACTOR | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000140096 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
2 | 0.0000135178 | SCINTIMAMMOGRAPHY//TC 99M MIBI//TC 99M TETROFOSMIN |
3 | 0.0000132729 | W 188 RE 188 GENERATOR//MO 99 TC 99M GENERATOR//MO 99 |
4 | 0.0000114674 | TECHNETIUM 99M MERCAPTOACETYLTRIGLYCINE//RADIOCHEMICAL PURITY//RENAL AGENTS |
5 | 0.0000087027 | RHENIUMV//OXORHENIUMV//TECHNETIUM COMPLEXES |
6 | 0.0000083129 | RHENIUM 186 HEDP//BONE PAIN PALLIATION//STRONTIUM 89 |
7 | 0.0000071817 | MEDULLARY THYROID CARCINOMA//RET PROTO ONCOGENE//MEDULLARY THYROID CANCER |
8 | 0.0000064978 | MYOMATOUS ERYTHROCYTOSIS SYNDROME//EXTRAPULMONARY UPTAKE//LOWER EXTREMITY SWELLING |
9 | 0.0000050886 | AMYLOID GOITER//AMYLOID GOITRE//AMORPHOUS DEPOSITS |
10 | 0.0000050830 | PULMONARY OSSIFICATION//METASTATIC PULMONARY CALCIFICATION//EXTRAOSSEOUS ACCUMULATION |